Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hance

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Thorax|August 1, 1987
Role of mast cells in the pathogenesis of hypersensitivity pneumonitisP Soler, S Nioche, D Valeyre, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 1999
Effect of stimulation of human macrophages on intracellular survival of Mycobacterium bovis Bacillus Calmette-Guerin. Evaluation with a mycobacterial reporter strainM Bonay, F Bouchonnet, V Pelicic, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2004
Detection of minority populations of HIV-1 expressing the K103N resistance mutation in patients failing nevirapineDenise Lecossier, Nancy S Shulman, Laurence Morand-Joubert, et al.
Journal of Virology|December 1, 2017
Genetically Intact but Functionally Impaired HIV-1 Env Glycoproteins in the T-Cell ReservoirAnne de Verneuil, Julie Migraine, Fabrizio Mammano, et al.
Journal of Virology|June 20, 2001
Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapyA J Hance, V Lemiale, J Izopet, et al.
The Journal of Biological Chemistry|November 2, 2001
Productive HIV-1 infection of primary CD4+ T cells induces mitochondrial membrane permeabilization leading to a caspase-independent cell deathFrédéric Petit, Damien Arnoult, Jean-Daniel Lelièvre, et al.
Antiviral Therapy|April 28, 2006
Low genetic barrier to large increases in HIV-1 cross-resistance to protease inhibitors during salvage therapyLaurence Morand-Joubert, Charlotte Charpentier, Gwendoline Poizat, et al.
Microbiology Spectrum|June 30, 2022
Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated PatientsAlexandre Nicolas, Julie Migraine, Jacques Dutrieux, et al.
Journal of Virology|August 17, 2006
Role of the envelope genetic context in the development of enfuvirtide resistance in human immunodeficiency virus type 1-infected patientsBéatrice Labrosse, Laurence Morand-Joubert, Armelle Goubard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 29, 2015
The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis BMarc M Solomon, Mauro Schechter, Albert Y Liu, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Thorax|August 1, 1987
Role of mast cells in the pathogenesis of hypersensitivity pneumonitisP Soler, S Nioche, D Valeyre, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 1999
Effect of stimulation of human macrophages on intracellular survival of Mycobacterium bovis Bacillus Calmette-Guerin. Evaluation with a mycobacterial reporter strainM Bonay, F Bouchonnet, V Pelicic, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2004
Detection of minority populations of HIV-1 expressing the K103N resistance mutation in patients failing nevirapineDenise Lecossier, Nancy S Shulman, Laurence Morand-Joubert, et al.
Journal of Virology|December 1, 2017
Genetically Intact but Functionally Impaired HIV-1 Env Glycoproteins in the T-Cell ReservoirAnne de Verneuil, Julie Migraine, Fabrizio Mammano, et al.
Journal of Virology|June 20, 2001
Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapyA J Hance, V Lemiale, J Izopet, et al.
The Journal of Biological Chemistry|November 2, 2001
Productive HIV-1 infection of primary CD4+ T cells induces mitochondrial membrane permeabilization leading to a caspase-independent cell deathFrédéric Petit, Damien Arnoult, Jean-Daniel Lelièvre, et al.
Antiviral Therapy|April 28, 2006
Low genetic barrier to large increases in HIV-1 cross-resistance to protease inhibitors during salvage therapyLaurence Morand-Joubert, Charlotte Charpentier, Gwendoline Poizat, et al.
Microbiology Spectrum|June 30, 2022
Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated PatientsAlexandre Nicolas, Julie Migraine, Jacques Dutrieux, et al.
Journal of Virology|August 17, 2006
Role of the envelope genetic context in the development of enfuvirtide resistance in human immunodeficiency virus type 1-infected patientsBéatrice Labrosse, Laurence Morand-Joubert, Armelle Goubard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 29, 2015
The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis BMarc M Solomon, Mauro Schechter, Albert Y Liu, et al.
Pageof 16